Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGylated recombinant human growth hormone in pediatric GHD (Phase IV)
CTR20150437Phase 4Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of peg-somatropin in growth hormone deficiency (GHD), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Dec 2017; status: completed.
02
Drugs
peg-somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on CTR20150437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150437.